Caspase-7: a critical mediator of optic nerve injury-induced retinal ganglion cell death
Open Access
- 26 August 2015
- journal article
- research article
- Published by Springer Nature in Molecular Neurodegeneration
- Vol. 10 (1) , 40
Abstract
Axonal injury of the optic nerve (ON) is involved in various ocular diseases, such as glaucoma and traumatic optic neuropathy, which leads to apoptotic death of retinal ganglion cells (RGCs) and loss of vision. Caspases have been implicated in RGC pathogenesis. However, the role of caspase-7, a functionally unique caspase, in ON injury and RGC apoptosis has not been reported previously. The purpose of this study is to evaluate the role of caspase-7 in ON injury-induced RGC apoptosis. C57BL/6 (wildtype, WT) and caspase-7 knockout (Casp7 −/− ) mice were used. We show that ON crush activated caspase-7 and calpain-1, an upstream activator of caspase-7, in mouse RGCs, as well as hydrolysis of kinectin and co-chaperone P23, specific substrates of caspase-7. ON crush caused a progressive loss of RGCs to 28 days after injury. Knockout of caspase-7 partially and significantly protected against the ON injury-induced RGC loss; RGC density at 28 days post ON crush in Casp7 −/− mice was approximately twice of that in WT ON injured retinas. Consistent with changes in RGC counts, spectral-domain optical coherence tomography analysis revealed that ON crush significantly reduced the in vivo thickness of the ganglion cell complex layer (including ganglion cell layer, nerve fiber layer, and inner plexiform layer) in the retina. The ON crush-induced thinning of retinal layer was significantly ameliorated in Casp7 −/− mice when compared to WT mice. Moreover, electroretinography analysis demonstrated a decline in the positive component of scotopic threshold response amplitude in ON crushed eyes of the WT mice, whereas this RGC functional response was significantly higher in Casp7 −/− mice at 28 days post injury. Altogether, our findings indicate that caspase-7 plays a critical role in ON injury-induced RGC death, and inhibition of caspase-7 activity may be a novel therapeutic strategy for glaucoma and other neurodegenerative diseases of the retina.Keywords
This publication has 62 references indexed in Scilit:
- Caspase-7 ablation modulates UPR, reprograms TRAF2-JNK apoptosis and protects T17M rhodopsin mice from severe retinal degenerationCell Death & Disease, 2013
- JNK2 and JNK3 are major regulators of axonal injury-induced retinal ganglion cell deathNeurobiology of Disease, 2012
- Caspase-7 uses an exosite to promote poly(ADP ribose) polymerase 1 proteolysisProceedings of the National Academy of Sciences, 2012
- Global Functional Map of the p23 Molecular Chaperone Reveals an Extensive Cellular NetworkMolecular Cell, 2011
- Ocular neuroprotection by siRNA targeting caspase-2Cell Death & Disease, 2011
- Mitochondria and cell death: outer membrane permeabilization and beyondNature Reviews Molecular Cell Biology, 2010
- Mechanism of retinal ganglion cells death in secondary degeneration of the optic nerveExperimental Eye Research, 2010
- Caspase-7: A protease involved in apoptosis and inflammationThe International Journal of Biochemistry & Cell Biology, 2010
- Executioner caspase-3 and caspase-7 are functionally distinct proteasesProceedings of the National Academy of Sciences, 2008
- The Role of Calcium-Activated Protease Calpain in Experimental Retinal PathologySurvey of Ophthalmology, 2008